These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20574554)

  • 1. Small gifts sustain sales.
    Bausch J
    Dtsch Arztebl Int; 2010 Jun; 107(22):390-1. PubMed ID: 20574554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medication prices in Germany--how are they determined?].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
    [No Abstract]   [Full Text] [Related]  

  • 3. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Direct purchase of expensive medicine from the manufacturer may be required].
    Zimmermann GW
    MMW Fortschr Med; 2015 Jun; 157(11):12. PubMed ID: 26049324
    [No Abstract]   [Full Text] [Related]  

  • 5. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No more free drug samples?
    Chimonas S; Kassirer JP
    PLoS Med; 2009 May; 6(5):e1000074. PubMed ID: 19434227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug prices in the US.
    Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
    [No Abstract]   [Full Text] [Related]  

  • 8. Breaking up is hard to do: lessons learned from a pharma-free practice transformation.
    Evans D; Hartung DM; Beasley D; Fagnan LJ
    J Am Board Fam Med; 2013; 26(3):332-8. PubMed ID: 23657703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regress for expensive medicines? When costly therapies are not a problem].
    Nitz G
    MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
    [No Abstract]   [Full Text] [Related]  

  • 10. Election 2015: new arguments for pharmacare.
    Vogel L
    CMAJ; 2015 Nov; 187(17):E483-E484. PubMed ID: 26464142
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A higher bar--Vermont's new law on marketing prescribed products.
    Steinbrook R
    N Engl J Med; 2009 Jul; 361(1):8-9. PubMed ID: 19516028
    [No Abstract]   [Full Text] [Related]  

  • 13. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
    Lee J
    Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407
    [No Abstract]   [Full Text] [Related]  

  • 14. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
    Gudiksen KL; King JS
    J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
    [No Abstract]   [Full Text] [Related]  

  • 15. How to Reduce Prescription Drug Prices: First, Do No Harm.
    Atlas S
    Mo Med; 2020; 117(1):14-15. PubMed ID: 32158034
    [No Abstract]   [Full Text] [Related]  

  • 16. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2010 Oct; 10(10):11-7. PubMed ID: 20945262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication supply of privately insured patients in 2010].
    Wild F
    Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
    [No Abstract]   [Full Text] [Related]  

  • 18. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B
    BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
    [No Abstract]   [Full Text] [Related]  

  • 19. Doctors face compulsory system to declare gifts and hospitality from drug companies.
    O'Dowd A
    BMJ; 2015 Aug; 351():h4617. PubMed ID: 26311722
    [No Abstract]   [Full Text] [Related]  

  • 20. German doctors free to take cash from drug firms.
    Hyde R
    Lancet; 2012 Aug; 380(9841):551. PubMed ID: 22891373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.